National Health Industries Inc history

Kunitz, S. “Efficiency and Reform in the Financing and Organization of American Medicine in the Progressive Era.” Bulletin of the History of Medicine, 55 (1981): 497–515. [PubMed], [Web of Science ®], [Google Scholar]

While these divestitures and organizational changes were being effected, Revlon Group Incorporated purchased Revlon, Inc. in 1985 through a subsidiary created expressly for purchasing Revlon, Inc.

As part of this transformation, Revlon sold its ethical pharmaceutical business in 1986, and with it Meloy Laboratories, one of the three subsidiary companies through which Rev-Ion conducted its diagnostic products and services operations.

After reviewing the material, federal prosecutors were convinced that National Health had persuaded doctors from as far back as 1987 to order unnecessary blood tests by misleading them about how much the company was billing Medicare, the federally sponsored health care program.

The legal turmoil began in 1990, when a grand jury investigation was launched in response to accusations made the year before that National Health had manipulated doctors into ordering unnecessary blood tests.

All of these factors contributed to the growth of the blood-testing industry, which by the time National Health emerged on its own in 1991 represented a $26 billion business.

In December 1992, National Health plead guilty to two felony counts of submitting false claims to the Civilian Health and Medical Program for the Uniformed Services, which provided health care to military families.

Unwilling to pay such an amount for Damon, National Health withdrew from the bidding contest and Corning acquired Damon in mid-1993.

In June 1994, the company’s shareholders approved a resolution to reorganize National Health into a holding company to facilitate such acquisitions.

In 1996, Clinton signed the Health Insurance Portability and Accountability Act (HIPAA), which established privacy standards for individuals.

offers prescription drug coverage to seniors and people with disabilities, starting in 2006;

The first open enrollment season for the Marketplace started in October 2013, and it was rocky, to say the least.

In 2015, health expenditures accounted for 11% of GDP in France, 11.1% in Germany, 11.2% in Japan, 9.8% in the UK, and 16.9% in the US.2 Moreover, this phenomenon is not limited to developed countries.

Nevertheless, 8 million people signed up for insurance through the ACA Marketplace during the first open enrollment season, with enrollment peaking in 2016 at 12.2 million (with 10 million of those receiving subsidies to help pay for insurance).

Since Donald Trump was sworn in as the 45th President of the United States on January 20, 2017, many have questioned what would happen with our healthcare system — specifically, what would happen to the ACA, since Donald Trump ran on a platform of “repealing and replacing” the bill.

According to the Kaiser Family Foundation, the ACA has covered an average of 11.3 million annually since its inception, though 8.5% of the United States population (roughly 27.5 million Americans) remain uninsured, as reported by the KKF in 2018.

Hungry to notch a win on healthcare prior to the 2020 election, the Trump administration continues to push ahead on initiatives designed to reign-in healthcare costs.